Last reviewed · How we verify

NCT05769452: nexiva

Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications

Completed NA Last updated 15 March 2023
What this trial tests

NA trial testing closed IV catheter system (BD Nexiva™) in Catheter Complications in 214 participants. Completed in 30 November 2022.

Timeline
1 April 2022
Primary endpoint
15 November 2022
30 November 2022

Quick facts

Lead sponsorGülçin Özalp Gerçeker
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment214
Start date1 April 2022
Primary completion15 November 2022
Estimated completion30 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gülçin Özalp Gerçeker

Who can join

Adults 1 to 12, any sex, with Catheter Complications or Catheter Leakage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Peripheral intravenous catheters (PIVCs) can be used frequently in pediatric hematology oncology patients. There are different types of PIVCs as open and closed. There are studies on adults using the closed IV catheter system, which is a type of PICK. However, no study was found in the literature in which the closed IV catheter system was used in the pediatric population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Catheter Complications

Currently open trials in the same condition.

Other Gülçin Özalp Gerçeker trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05769452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing